Search results
Results From The WOW.Com Content Network
In July 2020, Pfizer and BioNTech announced that two of the partners' four mRNA vaccine candidates had won fast track designation from the FDA. [125] The company began Phase II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95 billion for 100 million doses of the vaccine by the US government. [ 126 ]
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
Download as PDF; Printable version; From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Pfizer–BioNTech COVID-19 vaccine; Retrieved from " ...
Kathrin U. Jansen (born 1958) is the former [1] Head of Vaccine Research and Development at Pfizer.She previously led the development of the HPV vaccine and newer versions of the pneumococcal conjugate vaccine (), and is working with BioNTech to create a COVID-19 vaccine using mRNA (Pfizer–BioNTech COVID-19 vaccine) that was approved for Emergency Use Authorization in the United States on ...
At the beginning of the COVID-19 pandemic, Ogbuagu shifted his focus from AIDS/HIV research and patient care to lead vaccine trials for COVID-19 at the Yale Center for Clinical Investigation where he was a PI on the Pfizer-BioNtech COVID-19 mRNA vaccine trial arms at Yale in adults as well as the pediatric studies for12-15 year-olds and 6 month ...
Download QR code; Print/export Download as PDF; Printable version; In other projects Wikimedia Commons; Wikidata item; Appearance. ... Pfizer–BioNTech COVID-19 ...
Download QR code; Print/export Download as PDF; Printable version; Appearance. move to sidebar hide. From Wikipedia, the free encyclopedia ...
Pfizer–BioNTech Moderna Days 0 and 28 Days 0 and 112 Phase II (1,200) [339] May 2021 – Mar 2023, Canada: Pfizer–BioNTech Moderna Pfizer–BioNTech Moderna Days 0 and 42 Phase II (400) [340] May 2021 – Jan 2022, France: Oxford–AstraZeneca Pfizer–BioNTech Days 0 and 28 Days 0 and 21–49 Phase II (3,000) [341] May–Dec 2021, Austria ...